ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

Synthesis and Structure-Activity Relationships of Novel Naphthalenic and Bioisosteric Related Amidic Derivatives as Melatonin Receptor Ligands

Cite this: J. Med. Chem. 1994, 37, 20, 3231–3239
Publication Date (Print):September 1, 1994
https://doi.org/10.1021/jm00046a006
    ACS Legacy Archive

    Article Views

    1161

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 124 publications.

    1. Jaehee Lee, Xuan Ju, Miseon Lee, Qi Jiang, Hwanjong Jang, Wan Shin Kim, Linglin Wu, Suja Williams, Xiao-Jun Wang, Xingzhong Zeng, Jenna Payne, Zhengxu S. Han. Copper Catalyzed Regioselective and Stereospecific Aziridine Opening with Pyridyl Grignard Nucleophiles. Organic Letters 2022, 24 (14) , 2655-2659. https://doi.org/10.1021/acs.orglett.2c00703
    2. Marcos Antonio Ferreira, Jr., Hatylas Azevedo, Alessandra Mascarello, Natanael Dante Segretti, Elisa Russo, Valter Russo, Cristiano Ruch Werneck Guimarães. Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese Rats. Journal of Medicinal Chemistry 2021, 64 (4) , 1904-1929. https://doi.org/10.1021/acs.jmedchem.0c00627
    3. Nicholas A. Meanwell. Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. Journal of Medicinal Chemistry 2018, 61 (14) , 5822-5880. https://doi.org/10.1021/acs.jmedchem.7b01788
    4. Mario de la Fuente Revenga, Nerea Fernández-Sáez, Clara Herrera-Arozamena, José A. Morales-García, Sandra Alonso-Gil, Ana Pérez-Castillo, Daniel-Henri Caignard, Silvia Rivara, and María Isabel Rodríguez-Franco . Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential. Journal of Medicinal Chemistry 2015, 58 (12) , 4998-5014. https://doi.org/10.1021/acs.jmedchem.5b00245
    5. Darius. P. Zlotos, Ralf Jockers, Erika Cecon, Silvia Rivara, and Paula A. Witt-Enderby . MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential. Journal of Medicinal Chemistry 2014, 57 (8) , 3161-3185. https://doi.org/10.1021/jm401343c
    6. Daniele Pala, Thijs Beuming, Woody Sherman, Alessio Lodola, Silvia Rivara, and Marco Mor . Structure-Based Virtual Screening of MT2 Melatonin Receptor: Influence of Template Choice and Structural Refinement. Journal of Chemical Information and Modeling 2013, 53 (4) , 821-835. https://doi.org/10.1021/ci4000147
    7. Annalida Bedini,, Gilberto Spadoni,, Giuseppe Gatti,, Simone Lucarini,, Giorgio Tarzia,, Silvia Rivara,, Simone Lorenzi,, Alessio Lodola,, Marco Mor,, Valeria Lucini,, Marilou Pannacci, and, Francesco Scaglione. Design and Synthesis of N-(3,3-Diphenylpropenyl)alkanamides as a Novel Class of High-Affinity MT2-Selective Melatonin Receptor Ligands. Journal of Medicinal Chemistry 2006, 49 (25) , 7393-7403. https://doi.org/10.1021/jm060850a
    8. Silvia Rivara,, Marco Mor,, Claudia Silva,, Valentina Zuliani,, Federica Vacondio,, Gilberto Spadoni,, Annalida Bedini,, Giorgio Tarzia,, Valeria Lucini,, Marilou Pannacci,, Franco Fraschini, and, Pier Vincenzo Plazzi. Three-Dimensional Quantitative Structure−Activity Relationship Studies on Selected MT1 and MT2 Melatonin Receptor Ligands:  Requirements for Subtype Selectivity and Intrinsic Activity Modulation. Journal of Medicinal Chemistry 2003, 46 (8) , 1429-1439. https://doi.org/10.1021/jm020982d
    9. Carole Descamps-François,, Saïd Yous,, Philippe Chavatte,, Valérie Audinot,, Anne Bonnaud,, Jean A. Boutin,, Philippe Delagrange,, Caroline Bennejean,, Pierre Renard, and, Daniel Lesieur. Design and Synthesis of Naphthalenic Dimers as Selective MT1 Melatoninergic Ligands. Journal of Medicinal Chemistry 2003, 46 (7) , 1127-1129. https://doi.org/10.1021/jm0255872
    10. Valérie Wallez,, Sophie Durieux-Poissonnier,, Philippe Chavatte,, Jean A. Boutin,, Valérie Audinot,, Jean-Paul Nicolas,, Caroline Bennejean,, Philippe Delagrange,, Pierre Renard, and, Daniel Lesieur. Synthesis and Structure−Affinity−Activity Relationships of Novel Benzofuran Derivatives as MT2 Melatonin Receptor Selective Ligands. Journal of Medicinal Chemistry 2002, 45 (13) , 2788-2800. https://doi.org/10.1021/jm0005252
    11. Encarnación Camacho,, Josefa León,, Adoración Carrión,, Antonio Entrena,, Germaine Escames,, Huda Khaldy,, Darío Acuña-Castroviejo,, Miguel A. Gallo, and, Antonio Espinosa. Inhibition of nNOS Activity in Rat Brain by Synthetic Kynurenines:  Structure−Activity Dependence. Journal of Medicinal Chemistry 2002, 45 (2) , 263-274. https://doi.org/10.1021/jm010916w
    12. Gilberto Spadoni,, Cesarino Balsamini,, Giuseppe Diamantini,, Andrea Tontini, and, Giorgio Tarzia, , Marco Mor,, Silvia Rivara, and, Pier Vincenzo Plazzi, , Romolo Nonno,, Valeria Lucini,, Marilou Pannacci,, Franco Fraschini, and, Bojidar Michaylov Stankov. 2-N-Acylaminoalkylindoles:  Design and Quantitative Structure−Activity Relationship Studies Leading to MT2-Selective Melatonin Antagonists. Journal of Medicinal Chemistry 2001, 44 (18) , 2900-2912. https://doi.org/10.1021/jm001125h
    13. Carole Jellimann,, Monique Mathé-Allainmat,, Jean Andrieux,, Stéphane Kloubert,, Jean A. Boutin,, Jean-Paul Nicolas,, Caroline Bennejean,, Philippe Delagrange, and, Michel Langlois. Synthesis of Phenalene and Acenaphthene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors. Journal of Medicinal Chemistry 2000, 43 (22) , 4051-4062. https://doi.org/10.1021/jm000922c
    14. Edward A. Wintner and, Ciamac C. Moallemi. Quantized Surface Complementarity Diversity (QSCD):  A Model Based on Small Molecule−Target Complementarity. Journal of Medicinal Chemistry 2000, 43 (10) , 1993-2006. https://doi.org/10.1021/jm990504b
    15. Carole Jellimann,, Monique Mathé-Allainmat,, Jean Andrieux,, Pierre Renard,, Philippe Delagrange, and, Michel Langlois. Melatonergic Properties of the (+)- and (−)-Enantiomers of N-(4-Methoxy-2,3-dihydro-1H-phenalen-2-yl)amide Derivatives. Journal of Medicinal Chemistry 1999, 42 (6) , 1100-1105. https://doi.org/10.1021/jm9804937
    16. Christophe Marot,, Philippe Chavatte,, Luc Morin-Allory,, Marie Claude Viaud,, Gérald Guillaumet,, Pierre Renard,, Daniel Lesieur, and, André Michel. Pharmacophoric Search and 3D-QSAR Comparative Molecular Field Analysis Studies on Agonists of Melatonin Sheep Receptors. Journal of Medicinal Chemistry 1998, 41 (23) , 4453-4465. https://doi.org/10.1021/jm980026p
    17. Gilberto Spadoni,, Cesarino Balsamini,, Annalida Bedini,, Giuseppe Diamantini,, Barbara Di Giacomo,, Andrea Tontini, and, Giorgio Tarzia, , Marco Mor,, Pier Vincenzo Plazzi, and, Silvia Rivara, , Romolo Nonno,, Marilou Pannacci,, Valeria Lucini,, Franco Fraschini, and, Bojidar Michaylov Stankov. 2-[N-Acylamino(C1−C3)alkyl]indoles as MT1 Melatonin Receptor Partial Agonists, Antagonists, and Putative Inverse Agonists. Journal of Medicinal Chemistry 1998, 41 (19) , 3624-3634. https://doi.org/10.1021/jm970721h
    18. Marco Mor,, Silvia Rivara,, Claudia Silva,, Fabrizio Bordi, and, Pier Vincenzo Plazzi, , Gilberto Spadoni,, Giuseppe Diamantini,, Cesarino Balsamini, and, Giorgio Tarzia, , Franco Fraschini,, Valeria Lucini,, Romolo Nonno, and, Bojidar Michaylov Stankov. Melatonin Receptor Ligands:  Synthesis of New Melatonin Derivatives and Comprehensive Comparative Molecular Field Analysis (CoMFA) Study. Journal of Medicinal Chemistry 1998, 41 (20) , 3831-3844. https://doi.org/10.1021/jm9810093
    19. Giorgio Tarzia,, Giuseppe Diamantini,, Barbara Di Giacomo, and, Gilberto Spadoni, , Daniele Esposti, , Romolo Nonno,, Valeria Lucini,, Marilou Pannacci,, Franco Fraschini, and, Bojidar Michaylov Stankov. 1-(2-Alkanamidoethyl)-6-methoxyindole Derivatives:  A New Class of Potent Indole Melatonin Analogues. Journal of Medicinal Chemistry 1997, 40 (13) , 2003-2010. https://doi.org/10.1021/jm960653j
    20. Sames Sicsic,, Isabelle Serraz,, Jean Andrieux,, Béatrice Brémont,, Monique Mathé-Allainmat,, Annie Poncet,, Shuren Shen, and, Michel Langlois. Three-Dimensional Quantitative Structure−Activity Relationship of Melatonin Receptor Ligands:  A Comparative Molecular Field Analysis Study. Journal of Medicinal Chemistry 1997, 40 (5) , 739-748. https://doi.org/10.1021/jm960680+
    21. Monique Mathé-Allainmat,, Florence Gaudy,, Sames Sicsic,, Anne-Laure Dangy-Caye,, Shuren Shen,, Béatrice Brémont,, Zohra Benatalah,, Michel Langlois,, Pierre Renard, and, Philippe Delagrange. Synthesis of 2-Amido-2,3-dihydro-1H-phenalene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors. Journal of Medicinal Chemistry 1996, 39 (16) , 3089-3095. https://doi.org/10.1021/jm960219h
    22. Aqsa Kanwal, Uzma Afzal, Muhammad Zubair, Muhammad Imran, Nasir Rasool. Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review. RSC Advances 2024, 14 (10) , 6948-6971. https://doi.org/10.1039/D3RA06391G
    23. Yuxi Gao, Lijuan Gao, Endiao Zhu, Yunhong Yang, Mi Jie, Jiaqian Zhang, Zhiqiang Pan, Chengfeng Xia. Nickel/photoredox dual catalyzed arylalkylation of nonactivated alkenes. Nature Communications 2023, 14 (1) https://doi.org/10.1038/s41467-023-43748-4
    24. Gian Marco Elisi, Laura Scalvini, Alessio Lodola, Annalida Bedini, Gilberto Spadoni, Silvia Rivara. In silico drug discovery of melatonin receptor ligands with therapeutic potential. Expert Opinion on Drug Discovery 2022, 17 (4) , 343-354. https://doi.org/10.1080/17460441.2022.2043846
    25. Céline Legros, Said Yous, Jean A. Boutin. Alternative Ligands at Melatonin Receptors. 2022, 151-162. https://doi.org/10.1007/978-1-0716-2593-4_19
    26. Navjeet Kaur. Synthesis of heterocycles from cyanide, oxime, and azo compounds using Raney nickel. 2022, 81-118. https://doi.org/10.1016/B978-0-323-99492-7.00003-2
    27. Yiqiang Cao, Fei Wang, Yonggang Wang, Jiang Long. Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model. Aging 2021, 13 (10) , 13548-13559. https://doi.org/10.18632/aging.202836
    28. Jean A. Boutin, Paula A. Witt‐Enderby, Christoph Sotriffer, Darius P. Zlotos. Melatonin receptor ligands: A pharmaco‐chemical perspective. Journal of Pineal Research 2020, 69 (3) https://doi.org/10.1111/jpi.12672
    29. Andrew Tsotinis, Ioannis P. Papanastasiou. Synthetic Melatonin Receptor Agonists and Antagonists. 2020https://doi.org/10.5772/intechopen.91424
    30. Clara Herrera-Arozamena, Martín Estrada-Valencia, Concepción Pérez, Laura Lagartera, José A. Morales-García, Ana Pérez-Castillo, Juan Felipe Franco-Gonzalez, Patrycja Michalska, Pablo Duarte, Rafael León, Manuela G. López, Alberto Mills, Federico Gago, Ángel Juan García-Yagüe, Raquel Fernández-Ginés, Antonio Cuadrado, María Isabel Rodríguez-Franco. Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties. European Journal of Medicinal Chemistry 2020, 190 , 112090. https://doi.org/10.1016/j.ejmech.2020.112090
    31. Su-Yan Wang, Xin-Chi Shi, Pedro Laborda. Indole-based melatonin analogues: Synthetic approaches and biological activity. European Journal of Medicinal Chemistry 2020, 185 , 111847. https://doi.org/10.1016/j.ejmech.2019.111847
    32. Paul Le Baccon-Sollier, Yohan Malki, Morgane Maye, Lamiaa M. A. Ali, Laure Lichon, Pierre Cuq, Laure-Anaïs Vincent, Nicolas Masurier. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity. Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35 (1) , 935-949. https://doi.org/10.1080/14756366.2020.1748024
    33. Tao Wang, Owen B. Wallace, Zhongxing Zhang, Haiquan Fang, Zhong Yang, Brett A. Robinson, Timothy P. Spicer, Yi-Fei Gong, Wade S. Blair, Pei-Yong Shi, Pin-Fang Lin, Milind Deshpande, Nicholas A. Meanwell, John F. Kadow. A survey of core replacements in indole-based HIV-1 attachment inhibitors. Bioorganic & Medicinal Chemistry Letters 2019, 29 (11) , 1423-1429. https://doi.org/10.1016/j.bmcl.2019.03.018
    34. Benjamin Stauch, Linda C. Johansson, John D. McCorvy, Nilkanth Patel, Gye Won Han, Xi-Ping Huang, Cornelius Gati, Alexander Batyuk, Samuel T. Slocum, Andrii Ishchenko, Wolfgang Brehm, Thomas A. White, Nairie Michaelian, Caleb Madsen, Lan Zhu, Thomas D. Grant, Jessica M. Grandner, Anna Shiriaeva, Reid H. J. Olsen, Alexandra R. Tribo, Saïd Yous, Raymond C. Stevens, Uwe Weierstall, Vsevolod Katritch, Bryan L. Roth, Wei Liu, Vadim Cherezov. Structural basis of ligand recognition at the human MT1 melatonin receptor. Nature 2019, 569 (7755) , 284-288. https://doi.org/10.1038/s41586-019-1141-3
    35. Elodie Landagaray, Mohamed Ettaoussi, Marouan Rami, Jean A. Boutin, Daniel-Henri Caignard, Philippe Delagrange, Patricia Melnyk, Pascal Berthelot, Saïd Yous. New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation. European Journal of Medicinal Chemistry 2017, 127 , 621-631. https://doi.org/10.1016/j.ejmech.2016.12.013
    36. Hande Gurer-Orhan, Cigdem Karaaslan, Senem Ozcan, Omidreza Firuzi, Marjan Tavakkoli, Luciano Saso, Sibel Suzen. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage. Bioorganic & Medicinal Chemistry 2016, 24 (8) , 1658-1664. https://doi.org/10.1016/j.bmc.2016.02.039
    37. C. Legros, C. Brasseur, P. Delagrange, P. Ducrot, O. Nosjean, J. A. Boutin. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors. Journal of Pharmacology and Experimental Therapeutics 2016, 356 (3) , 681-692. https://doi.org/10.1124/jpet.115.229989
    38. Elodie Landagaray, Mohamed Ettaoussi, Romain Duroux, Jean A. Boutin, Daniel-Henri Caignard, Philippe Delagrange, Patricia Melnyk, Pascal Berthelot, Saïd Yous. Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives. European Journal of Medicinal Chemistry 2016, 109 , 360-370. https://doi.org/10.1016/j.ejmech.2015.12.047
    39. Jürgen Sandow. Effects on Different Peptide Hormones. 2016, 3691-3745. https://doi.org/10.1007/978-3-319-05392-9_84
    40. Mario de la Fuente Revenga, Clara Herrera-Arozamena, Nerea Fernández-Sáez, Gema Barco, Itxaso García-Orue, David Sugden, Silvia Rivara, María Isabel Rodríguez-Franco. New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization. European Journal of Medicinal Chemistry 2015, 103 , 370-373. https://doi.org/10.1016/j.ejmech.2015.09.003
    41. Jürgen Sandow. Effects on Different Peptide Hormones. 2015, 1-64. https://doi.org/10.1007/978-3-642-27728-3_84-1
    42. Darius P. Zlotos, Noura M. Riad, Mai B. Osman, Bala R. Dodda, Paula A. Witt-Enderby. Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT 1 selectivity. MedChemComm 2015, 6 (7) , 1340-1344. https://doi.org/10.1039/C5MD00190K
    43. Christos I. Stathakis, Efstratios Neokosmidis, Theocharis V. Koftis. A Scalable Synthesis of the Antidepressant Agomelatine by a Tandem Allylic Chlorination–Isomerization Process. European Journal of Organic Chemistry 2014, 2014 (29) , 6376-6379. https://doi.org/10.1002/ejoc.201402886
    44. Desirée C. Schuck, Alessandro K. Jordão, Myna Nakabashi, Anna C. Cunha, Vitor F. Ferreira, Célia R.S. Garcia. Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum. European Journal of Medicinal Chemistry 2014, 78 , 375-382. https://doi.org/10.1016/j.ejmech.2014.03.055
    45. Elodie Landagaray, Mohamed Ettaoussi, Véronique Leclerc, Balla Traoré, Valérie Perez, Olivier Nosjean, Jean A. Boutin, Daniel-Henri Caignard, Philippe Delagrange, Pascal Berthelot, Saïd Yous. New melatonin (MT1/MT2) ligands: Design and synthesis of (8,9-dihydro-7H-furo[3,2-f]chromen-1-yl) derivatives. Bioorganic & Medicinal Chemistry 2014, 22 (3) , 986-996. https://doi.org/10.1016/j.bmc.2013.12.054
    46. Céline Legros, Séverine Devavry, Sarah Caignard, Clémence Tessier, Philippe Delagrange, Christine Ouvry, Jean A Boutin, Olivier Nosjean. Melatonin MT 1 and MT 2 receptors display different molecular pharmacologies only in the G ‐protein coupled state. British Journal of Pharmacology 2014, 171 (1) , 186-201. https://doi.org/10.1111/bph.12457
    47. Peter S. Dragovich, Kenneth W. Bair, Timm Baumeister, Yen-Ching Ho, Bianca M. Liederer, Xiongcai Liu, Yongbo Liu, Thomas O’Brien, Jason Oeh, Deepak Sampath, Nicholas Skelton, Leslie Wang, Weiru Wang, Hongxing Wu, Yang Xiao, Po-wai Yuen, Mark Zak, Lei Zhang, Xiaozhang Zheng. Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorganic & Medicinal Chemistry Letters 2013, 23 (17) , 4875-4885. https://doi.org/10.1016/j.bmcl.2013.06.090
    48. E Karakus, Z Halici, A Albayrak, B Polat, Y Bayir, İ Kiki, E Cadirci, A Topcu, S Aksak. Agomelatine. Human & Experimental Toxicology 2013, 32 (8) , 846-857. https://doi.org/10.1177/0960327112472994
    49. Yu Huang, Jia-Liang Zhong, Shan Hanbin, Min Li, Zhe-Dong Yuan. (1-{[2-(6-Methoxynaphthalen-1-yl)ethyl]amino}ethylidene)oxidanium bromide monohydrate. Acta Crystallographica Section C Crystal Structure Communications 2012, 68 (8) , o308-o310. https://doi.org/10.1107/S0108270112029885
    50. Sibel Suzen, Seyhan Sezen Cihaner, Tulay Coban. Synthesis and Comparison of Antioxidant Properties of Indole‐Based Melatonin Analogue Indole Amino Acid Derivatives. Chemical Biology & Drug Design 2012, 79 (1) , 76-83. https://doi.org/10.1111/j.1747-0285.2011.01216.x
    51. Gilberto Spadoni, Annalida Bedini, Silvia Rivara, Marco Mor. Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment. CNS Neuroscience & Therapeutics 2011, 17 (6) , 733-741. https://doi.org/10.1111/j.1755-5949.2010.00197.x
    52. Regina M Carney, Richard C Shelton. Agomelatine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 2011, 12 (15) , 2411-2419. https://doi.org/10.1517/14656566.2011.607812
    53. Saïd El Kazzouli, Amaury Griffon du Bellay, Sabine Berteina-Raboin, Philippe Delagrange, Daniel-Henry Caignard, Gérald Guillaumet. Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands. European Journal of Medicinal Chemistry 2011, 46 (9) , 4252-4257. https://doi.org/10.1016/j.ejmech.2011.06.030
    54. Véronique Leclerc, Mohamed Ettaoussi, Marouan Rami, Amaury Farce, Jean Albert Boutin, Philippe Delagrange, Daniel-Henri Caignard, Pierre Renard, Pascal Berthelot, Saïd Yous. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3. European Journal of Medicinal Chemistry 2011, 46 (5) , 1622-1629. https://doi.org/10.1016/j.ejmech.2011.02.010
    55. E. Trecherel, M. Batailler, D. Chesneau, P. Delagrange, B. Malpaux, P. Chemineau, M. Migaud. Functional characterization of polymorphic variants for ovine MT1 melatonin receptors: Possible implication for seasonal reproduction in sheep. Animal Reproduction Science 2010, 122 (3-4) , 328-334. https://doi.org/10.1016/j.anireprosci.2010.10.007
    56. Margarita L. Dubocovich, Philippe Delagrange, Diana N. Krause, David Sugden, Daniel P. Cardinali, James Olcese. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin Receptors. Pharmacological Reviews 2010, 62 (3) , 343-380. https://doi.org/10.1124/pr.110.002832
    57. Wen-bin Wei, Ru Jia, Jie Sun, Hai-Bo Wang. 2-(7-Methoxy-1-naphthyl)acetonitrile. Acta Crystallographica Section E Structure Reports Online 2010, 66 (7) , o1868-o1868. https://doi.org/10.1107/S1600536810024372
    58. Alessia Carocci, Giovanni Lentini, Alessia Catalano, Maria Maddalena Cavalluzzi, Claudio Bruno, Marilena Muraglia, Nicola Antonio Colabufo, Nicoletta Galeotti, Filomena Corbo, Rosanna Matucci, Carla Ghelardini, Carlo Franchini. Chiral Aryloxyalkylamines: Selective 5‐HT 1B/1D Activation and Analgesic Activity. ChemMedChem 2010, 5 (5) , 696-704. https://doi.org/10.1002/cmdc.200900530
    59. Christophe Mésangeau, Basile Pérès, Carole Descamps-François, Philippe Chavatte, Valérie Audinot, Sophie Coumailleau, Jean A. Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel H. Caignard, Pascal Berthelot, Saïd Yous. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT1 melatoninergic ligands. Bioorganic & Medicinal Chemistry 2010, 18 (10) , 3426-3436. https://doi.org/10.1016/j.bmc.2010.04.008
    60. C. Haldar, R. Ahmad. Photoimmunomodulation and melatonin. Journal of Photochemistry and Photobiology B: Biology 2010, 98 (2) , 107-117. https://doi.org/10.1016/j.jphotobiol.2009.11.014
    61. Gökce Gürkök, Tulay Coban, Sibel Suzen. Melatonin analogue new indole hydrazide/hydrazone derivatives with antioxidant behavior: Synthesis and structure–activity relationships. Journal of Enzyme Inhibition and Medicinal Chemistry 2009, 24 (2) , 506-515. https://doi.org/10.1080/14756360802218516
    62. Sophie Poissonnier-Durieux, Mohamed Ettaoussi, Basile Pérès, Jean A. Boutin, Valérie Audinot, Caroline Bennejean, Philippe Delagrange, Daniel Henri Caignard, Pierre Renard, Pascal Berthelot, Daniel Lesieur, Saïd Yous. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT2 melatoninergic ligands. Bioorganic & Medicinal Chemistry 2008, 16 (18) , 8339-8348. https://doi.org/10.1016/j.bmc.2008.08.052
    63. Valérie Audinot, Anne Bonnaud, Line Grandcolas, Marianne Rodriguez, Nadine Nagel, Jean-Pierre Galizzi, Ales Balik, Sophie Messager, David G. Hazlerigg, Perry Barrett, Philippe Delagrange, Jean A. Boutin. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors. Biochemical Pharmacology 2008, 75 (10) , 2007-2019. https://doi.org/10.1016/j.bcp.2008.02.022
    64. Mohamed Ettaoussi, Basile Péres, Fréderique Klupsch, Philippe Delagrange, Jean-A. Boutin, Pierre Renard, Daniel-H. Caignard, Philippe Chavatte, Pascal Berthelot, Daniel Lesieur, Saïd Yous. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3. Bioorganic & Medicinal Chemistry 2008, 16 (9) , 4954-4962. https://doi.org/10.1016/j.bmc.2008.03.036
    65. Paola Ciapetti, Bruno Giethlen. Molecular Variations Based on Isosteric Replacements. 2008, 290-342. https://doi.org/10.1016/B978-0-12-374194-3.00015-9
    66. Paola Ciapetti, Bruno Giethlen. Molecular Variations Based on Isosteric Replacements. 2008, 181-241. https://doi.org/10.1016/B978-0-12-417205-0.00008-0
    67. Andrew Tsotinis, Andreas Eleutheriades, Kate A. Hough, Kathryn Davidson, David Sugden. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines. Bioorganic Chemistry 2007, 35 (2) , 189-204. https://doi.org/10.1016/j.bioorg.2006.11.006
    68. V. G. Nenajdenko, S. V. Pronin, E. S. Balenkova. Synthesis of aminoalkylpyrazoles and-isoxazoles from cyclic β-(trifluoroacetyl) enamines. Russian Chemical Bulletin 2007, 56 (2) , 336-344. https://doi.org/10.1007/s11172-007-0055-7
    69. Trevor R Norman, Graham D Burrows. Emerging treatments for major depression. Expert Review of Neurotherapeutics 2007, 7 (2) , 203-213. https://doi.org/10.1586/14737175.7.2.203
    70. Hans Gerhard Vogel. Endocrinology. 2007, 1719-1916. https://doi.org/10.1007/978-3-540-70995-4_15
    71. Trevor R. Norman. Prospects for the Treatment of Depression. Australian & New Zealand Journal of Psychiatry 2006, 40 (5) , 394-401. https://doi.org/10.1080/j.1440-1614.2006.01814.x
    72. Jan Elsner, Frank Boeckler, Kathryn Davidson, David Sugden, Peter Gmeiner. Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation. Bioorganic & Medicinal Chemistry 2006, 14 (6) , 1949-1958. https://doi.org/10.1016/j.bmc.2005.10.042
    73. Amaury Farce, Sebastien Dilly, Said Yous, Pascal Berthelot, Philippe Chavatte. Homology modelling of the serotoninergic 5-HT 2c receptor. Journal of Enzyme Inhibition and Medicinal Chemistry 2006, 21 (3) , 285-292. https://doi.org/10.1080/14756360600700608
    74. Darius P. Zlotos. Recent Advances in Melatonin Receptor Ligands. Archiv der Pharmazie 2005, 338 (5-6) , 229-247. https://doi.org/10.1002/ardp.200400996
    75. Christophe Mésangeau, Saïd Yous, Basile Pérès, Daniel Lesieur, Thierry Besson. Pictet–Spengler heterocyclizations via microwave-assisted degradation of DMSO. Tetrahedron Letters 2005, 46 (14) , 2465-2468. https://doi.org/10.1016/j.tetlet.2005.02.043
    76. Mercedes M. Leon-Blanco, Juan M. Guerrero, Russel J. Reiter, David Pozo. RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line. Cancer Letters 2004, 216 (1) , 73-80. https://doi.org/10.1016/j.canlet.2004.05.003
    77. David Pozo, Sofía García‐Mauriño, Juan M. Guerrero, Juan R. Calvo. mRNA expression of nuclear receptor RZR/ROR α , melatonin membrane receptor MT 1 , and hydroxindole‐ O ‐methyltransferase in different populations of human immune cells. Journal of Pineal Research 2004, 37 (1) , 48-54. https://doi.org/10.1111/j.1600-079X.2004.00135.x
    78. François Mailliet, Valérie Audinot, Benoit Malpaux, Anne Bonnaud, Philippe Delagrange, Martine Migaud, Perry Barrett, Marie-Claude Viaud-Massuard, Daniel Lesieur, François Lefoulon, Pierre Renard, Jean A. Boutin. Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors. Biochemical Pharmacology 2004, 67 (4) , 667-677. https://doi.org/10.1016/j.bcp.2003.09.037
    79. Brian M. Mathes, Kevin J. Hudziak, John M. Schaus, Yao-Chang Xu, David L. Nelson, David B. Wainscott, Suzanne E. Nutter, Wendy H. Gough, Theresa A. Branchek, John M. Zgombick, Sandra A. Filla. Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists. Bioorganic & Medicinal Chemistry Letters 2004, 14 (1) , 167-170. https://doi.org/10.1016/j.bmcl.2003.09.091
    80. Gilles Ferry, Caroline Ubeaud, Julien Mozo, Christophe Péan, Philippe Hennig, Marianne Rodriguez, Catherine Scoul, Anne Bonnaud, Olivier Nosjean, Jean‐Pierre Galizzi, Philippe Delagrange, Pierre Renard, Jean‐Paul Volland, Said Yous, Daniel Lesieur, Jean A. Boutin. New substrate analogues of human serotonin N ‐acetyltransferase produce in situ specific and potent inhibitors. European Journal of Biochemistry 2004, 271 (2) , 418-428. https://doi.org/10.1046/j.1432-1033.2003.03942.x
    81. P. Delagrange, J. Atkinson, J. A. Boutin, L. Casteilla, D. Lesieur, R. Misslin, S. Pellissier, L. Pénicaud, P. Renard. Therapeutic Perspectives for Melatonin Agonists and Antagonists. Journal of Neuroendocrinology 2003, 15 (4) , 442-448. https://doi.org/10.1046/j.1365-2826.2003.01016.x
    82. Isabelle Charton, Franck Suzenet, Jean A. Boutin, Valérie Audinot, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Gérald Guillaumet. Synthesis of 5-Substituted-2,3-dihydro-1,4-benzoxathiins: Biological Evaluation as Melatonin Receptors Ligands. Journal of Enzyme Inhibition and Medicinal Chemistry 2003, 18 (2) , 187-193. https://doi.org/10.1080/1475636032000096855
    83. Antonio Carrillo‐Vico, Sofía García‐Mauriño, Juan R. Calvo, Juan M. Guerrero. Melatonin counteracts the inhibitory effect of PGE 2 on IL‐2 production in human lymphocytes via its mt1 membrane receptor. The FASEB Journal 2003, 17 (6) , 755-757. https://doi.org/10.1096/fj.02-0501fje
    84. Saı̈d Yous, Sophie Durieux-Poissonnier, Emmanuelle Lipka-Belloli, Halim Guelzim, Christophe Bochu, Valérie Audinot, Jean A Boutin, Philippe Delagrange, Caroline Bennejean, Pierre Renard, Daniel Lesieur. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Bioorganic & Medicinal Chemistry 2003, 11 (5) , 753-759. https://doi.org/10.1016/S0968-0896(02)00473-X
    85. B. Claustrat. Melatonin and sleep-wake rhythm. 2003, 71-82. https://doi.org/10.1007/978-1-4615-0217-3_6
    86. N. Beaurain, C. Mésangeau, P. Chavatte, G. Ferry, V. Audinot, J.A. Boutin, P. Delagrange, C. Bennejean, S. Yous. Design, Synthesis and In Vitro Evaluation of Novel Derivatives as Serotonin N -Acetyltransferase Inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2002, 17 (6) , 409-414. https://doi.org/10.1080/1475636021000005721
    87. Guo-Hua Chu, Paula A. Witt-Enderby, Marla Jones, Pui-Kai Li. Synthesis and Pharmacological Analysis of High Affinity Melatonin Receptor Ligands.. Chemical and Pharmaceutical Bulletin 2002, 50 (2) , 272-275. https://doi.org/10.1248/cpb.50.272
    88. Andrew Tsotinis, Margarita Vlachou, Andreas Eleutheriades, Effie Prinea, Darren Ebreo, Muy-Teck The, David Sugden. Synthesis of N1-Phenethyl Substituted Indole Derivatives as New Melatoninergic Agonists and Antagonists.. Chemical and Pharmaceutical Bulletin 2002, 50 (1) , 31-39. https://doi.org/10.1248/cpb.50.31
    89. Valentine G Nenajdenko, Alexei S Karpov, Elizabeth S Balenkova. A new convenient approach to chiral β-aryl(heteroaryl)alkylamines. Tetrahedron: Asymmetry 2001, 12 (18) , 2517-2527. https://doi.org/10.1016/S0957-4166(01)00442-6
    90. Andrew Tsotinis, Maria Panoussopoulou, Sachi Sivananthan, David Sugden. Synthesis of new tricyclic melatoninergic ligands. Il Farmaco 2001, 56 (9) , 725-729. https://doi.org/10.1016/S0014-827X(01)01125-9
    91. Olivier Nosjean, Jean-Paul Nicolas, Frederique Klupsch, Philippe Delagrange, Emmanuel Canet, Jean A Boutin. Comparative pharmacological studies of melatonin receptors: mt1, mt2 and mt3/qr2. tissue distribution of mt3/qr2 11Abbreviations: MCA-NAT, methoxy-carbonylamino-N-acetyltrypta- mine, 2-[125I]-I-MCA-NAT, 2-[125I]-iodomethoxy-carbonylamino-N-acetyltryptamine; 2-IbMT, 2-iodo-N-butanoyl-5-methoxytryptamine; 4-P-PDOT, 4-phenyl-2-propionamido-tetraline; DH97, N-pentanoyl-2-benzyltryptamine; S20760, 5-methoxy-N-cyclopropanoyl-tryptamine; S24635, N-[2-(5-carbamoylbenzofuran-3-yl)ethyl]-acetamide; S25726, N-methyl-(3-{2-[(cyclopropylcarbonyl)-amino]ethyl}benzo[b]furan-5-yl)carbamate; S26553, N-methyl-{1-[2-(acetylamino)ethyl]-naphthalen-7-yl}carbamate.. Biochemical Pharmacology 2001, 61 (11) , 1369-1379. https://doi.org/10.1016/S0006-2952(01)00615-3
    92. Said Yous, Frédérique Klupsch, Isabelle Lesieur. SYNTHESIS OF 2(3 H )-BENZOXAZOLINONE DERIVATIVES AS POTENTIAL MELATONIN RECEPTOR LIGANDS. Organic Preparations and Procedures International 2001, 33 (1) , 75-80. https://doi.org/10.1080/00304940109356576
    93. Juan M. Guerrero, Sofia Garcia-Mauriño, David Pozo, Antonio Garcia-Pergañeda, Antonio Carrillo-Vico, Patrocinio Molinero, Carmen Osuna, Juan R. Calvo. Mechanisms Involved in the Immunomodulatory Effects of Melatonin on the Human Immune System. 2001, 408-416. https://doi.org/10.1007/978-3-642-59512-7_22
    94. Guo-Hua Chu, Pui-Kai Li. SYNTHESIS OF NAPHTHALENIC MELATONIN RECEPTOR LIGANDS. Synthetic Communications 2001, 31 (4) , 621-629. https://doi.org/10.1081/SCC-100000591
    95. Olivier Nosjean, Myriam Ferro, Francis Cogé, Philippe Beauverger, Jean-Michel Henlin, François Lefoulon, Jean-Luc Fauchère, Philippe Delagrange, Emmanuel Canet, Jean A. Boutin. Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2. Journal of Biological Chemistry 2000, 275 (40) , 31311-31317. https://doi.org/10.1074/jbc.M005141200
    96. Paula A. Witt-Enderby, Pui-Kai Li. Melatonin receptors and ligands. 2000, 321-354. https://doi.org/10.1016/S0083-6729(00)58030-3
    97. Isabelle Charton, Ahmed Mamai, Caroline Bennejean, Pierre Renard, Edward H. Howell, Béatrice Guardiola-Lemaı̂tre, Philippe Delagrange, Peter J. Morgan, Marie-Claude Viaud, Gérald Guillaumet. Substituted oxygenated heterocycles and thio-analogues: synthesis and biological evaluation as melatonin ligands. Bioorganic & Medicinal Chemistry 2000, 8 (1) , 105-114. https://doi.org/10.1016/S0968-0896(99)00265-5
    98. Cécile Pégurier, Sophie Curtet, Jean-Paul Nicolas, Jean A. Boutin, Philippe Delagrange, Pierre Renard, Michel Langlois. Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt 1 and MT 2 receptors. Bioorganic & Medicinal Chemistry 2000, 8 (1) , 163-171. https://doi.org/10.1016/S0968-0896(99)00285-0
    99. JUAN M. GUERRERO, DAVID POZO, SOFÍA GARCÍA‐MAURIÑO, C. OSUNA, P. MOLINERO, JUAN R. CALVO. Involvement of Nuclear Receptors in the Enhanced IL‐2 Production by Melatonin in Jurkat Cells. Annals of the New York Academy of Sciences 2000, 917 (1) , 397-403. https://doi.org/10.1111/j.1749-6632.2000.tb05404.x
    100. Monique Mathé-Allainmat, Marie Le Gall, Carole Jellimann, Jean Andrieux, Michel Langlois. Synthesis of β-Substituted Naphth-1-yl Ethylamido Derivatives as New Melatoninergic agonists. Bioorganic & Medicinal Chemistry 1999, 7 (12) , 2945-2952. https://doi.org/10.1016/S0968-0896(99)00236-9
    Load all citations

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    MENDELEY PAIRING EXPIRED
    Your Mendeley pairing has expired. Please reconnect